Labs / CDMO: development & manufacturing

Novoheart
Hong Kong, China · novoheart.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Novoheart develops bioengineered human heart constructs for drug discovery, disease modeling, and screening. It serves researchers and drug developers working on cardiac therapeutics, with laboratory locations in Boston, Hong Kong, and a Singapore facility coming soon.
They take quote requests by email.
What they offer
Human embryonic or induced pluripotent stem cell differentiation to ventricular cardiomyoc
Differentiates pluripotent stem cells into ventricular cardiomyocytes.
Mini-Heart engineered tissue assays using specified cell lines
Provides engineered human heart tissue assays built from specified cell lines.
Human Ventricular Cardiac Anisotropic Sheet (hvCAS)
Offers anisotropic sheet assays for cardiac modeling and testing.
Human Ventricular Cardiac Tissue Strip (hvCTS)
Offers tissue strip assays for contractility and related cardiac functional testing.
Human Heart-in-a-Jar™ / Human Ventricular Cardiac Organoid Chamber (hvCOC)
Provides a human heart-in-a-jar organoid chamber model for testing toxicity and efficacy.
Drug discovery
Supports drug discovery using human-specific cardiac models.
Cardiotoxicity screening
Screens compounds for cardiac toxicity.
Disease modeling of rare/genetic and acquired heart diseases
Builds disease models for rare, genetic, and acquired heart diseases.
Efficacy studies
Assesses therapeutic efficacy in cardiac models.
Dose titration and optimization
Evaluates dose response and optimization for treatments.
Patient cohort-specific responses to drug treatments
Tests responses to treatments in specified patient cohorts.
Screening and phenotyping services
Provides screening and phenotyping for cardiac models and compounds.
Research and development / consultation related to new disease models and therapeutics
Provides R&D and consultation for new disease models and therapeutics.
What they work on
- Modalities
- gene and cell products
- Species and models
- human pluripotent stem cells, human embryonic stem cells, human induced pluripotent stem cells, human ventricular cardiomyocytes, heart failure with preserved ejection fraction, COVID, arrhythmias, Long QT Syndrome, Friedreich's Ataxia
- Assays and studies
- electrophysiology, arrhythmia, contractility, pressure-volume, toxicity, efficacy, screening, phenotyping, dose response, cardiotoxicity
- Instruments and platforms
- CTScreen System Software, mini-Heart T-Monitor, mini-Heart T-Processor, mini-Heart T-Analyzer
- Therapeutic areas
- heart disease, cardiac therapeutics, drug discovery
- Sites
- Boston, USA · Hong Kong, Hong Kong · Singapore, Singapore
- Serves
- global
- Address
- 6 Tide Street, 2nd Floor, Boston, MA 02210, USA
- Founded
- 2014
Public records
- Ownership
- Novoheart Holdings Inc. · CA GLEIF
Similar labs. 3C Therapeutics, Alchem Laboratories Corporation, ARSI Canada Inc, Aurigene Pharmaceutical Services
Found in a contract services directory. Listing built from novoheart.com. Work here? Claim this listing.